Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder

Sponsor: University of Wisconsin, Madison
Collaborator: Revive Therapeutics, Ltd.
Recruitment Status: Not yet recruiting
First Posted: Apr 12, 2022

~

(Living reference work entry) Life-Threatening 3,4‐Methylenedioxyamphetamine (MDMA) Usage (Chu)

Published: Apr 13, 2022
Handbook of Substance Misuse and Addictions pp 1–10